{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:06:44Z","timestamp":1775653604306,"version":"3.50.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Engineering Board, Department of Science and Technology, India","award":["CRG\/2022\/005685"],"award-info":[{"award-number":["CRG\/2022\/005685"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03263-0","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:14:07Z","timestamp":1770398047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA mediated signaling and metabolic reprogramming in oral squamous cell carcinoma"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4497-8931","authenticated-orcid":false,"given":"Gunjankumari","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-7282","authenticated-orcid":false,"given":"Sitaram","family":"Harihar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"3263_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.oraloncology.2004.10.010","volume":"41","author":"SE Scott","year":"2005","unstructured":"Scott SE, Grunfeld EA, McGurk M. The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 2005;41:396\u2013403. https:\/\/doi.org\/10.1016\/j.oraloncology.2004.10.010.","journal-title":"Oral Oncol"},{"key":"3263_CR2","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.14219\/jada.archive.2001.0382","volume":"132","author":"S Silvermam","year":"2001","unstructured":"Silvermam S. Demographics and occurrence of oral and pharyngeal cancers: the outcomes, the trends, the challenge. J Am Dent Assoc. 2001;132:S7\u201311. https:\/\/doi.org\/10.14219\/jada.archive.2001.0382.","journal-title":"J Am Dent Assoc"},{"key":"3263_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/PATH.2306","volume":"214","author":"CJ Liu","year":"2008","unstructured":"Liu CJ, Liu TY, Kuo LT, et al. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol. 2008;214:489\u201397. https:\/\/doi.org\/10.1002\/PATH.2306.","journal-title":"J Pathol"},{"key":"3263_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4103\/JOMFP.JOMFP_241_16","volume":"21","author":"R Padma","year":"2017","unstructured":"Padma R, Kalaivani A, Sundaresan S, Sathish P. The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2017;21:461. https:\/\/doi.org\/10.4103\/JOMFP.JOMFP_241_16.","journal-title":"J Oral Maxillofac Pathol"},{"key":"3263_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/J.RO.2012.09.002","volume":"48","author":"MJ Walden","year":"2013","unstructured":"Walden MJ, Aygun N. Head and neck cancer. Semin Roentgenol. 2013;48:75\u201386. https:\/\/doi.org\/10.1053\/J.RO.2012.09.002.","journal-title":"Semin Roentgenol"},{"key":"3263_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP. Metazoan MicroRNAs. Cell. 2018;173:20\u201351. https:\/\/doi.org\/10.1016\/j.cell.2018.03.006.","journal-title":"Cell"},{"key":"3263_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1044-579X(03)00038-5","volume":"13","author":"MT McManus","year":"2003","unstructured":"McManus MT. MicroRNAs and cancer. Semin Cancer Biol. 2003;13:253\u20138. https:\/\/doi.org\/10.1016\/S1044-579X(03)00038-5.","journal-title":"Semin Cancer Biol"},{"key":"3263_CR8","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1093\/NAR\/GKR148","volume":"39","author":"MP Gantier","year":"2011","unstructured":"Gantier MP, McCoy CE, Rusinova I, et al. Analysis of MicroRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39:5692\u2013703. https:\/\/doi.org\/10.1093\/NAR\/GKR148.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3263_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13104-018-3378-6","volume":"11","author":"DC Muth","year":"2018","unstructured":"Muth DC, Powell BH, Zhao Z, Witwer KW. (2018) miRNAs in platelet-poor blood plasma and purified RNA are highly stable: a confirmatory study. BMC Research Notes 2018;11:(1) 273. https:\/\/doi.org\/10.1186\/S13104-018-3378-6","journal-title":"BMC research notes"},{"key":"3263_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1101\/GR.131037.111","volume":"22","author":"MB Clark","year":"2012","unstructured":"Clark MB, Johnston RL, Inostroza-Ponta M, et al. Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012;22:885\u201398. https:\/\/doi.org\/10.1101\/GR.131037.111.","journal-title":"Genome Res"},{"key":"3263_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/J.ORALONCOLOGY.2011.03.019","volume":"47","author":"BH Wu","year":"2011","unstructured":"Wu BH, Xiong XP, Jia J, Zhang WF. MicroRNAs: new actors in the oral cancer scene. Oral Oncol. 2011;47:314\u20139. https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2011.03.019.","journal-title":"Oral Oncol"},{"key":"3263_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/GAD.1540407","volume":"21","author":"SL Yong","year":"2007","unstructured":"Yong SL, Dutta A. The tumor suppressor MicroRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025\u201330. https:\/\/doi.org\/10.1101\/GAD.1540407.","journal-title":"Genes Dev"},{"key":"3263_CR13","doi-asserted-by":"publisher","first-page":"144936","DOI":"10.1016\/j.gene.2020.144936","volume":"757","author":"M Aali","year":"2020","unstructured":"Aali M, Mesgarzadeh AH, Najjary S, et al. Evaluating the role of MicroRNAs alterations in oral squamous cell carcinoma. Gene. 2020;757:144936. https:\/\/doi.org\/10.1016\/j.gene.2020.144936.","journal-title":"Gene"},{"key":"3263_CR14","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1038\/ONC.2008.274","volume":"27","author":"R Schickel","year":"2008","unstructured":"Schickel R, Boyerinas B, SM P, Peter M. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27:5959\u201374. https:\/\/doi.org\/10.1038\/ONC.2008.274.","journal-title":"Oncogene"},{"key":"3263_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-030-34025-4_10","volume":"1219","author":"F Carreira-Barbosa","year":"2020","unstructured":"Carreira-Barbosa F, Nunes SC. Wnt signaling: paths for cancer progression. Adv Exp Med Biol. 2020;1219:189\u2013202. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_10.","journal-title":"Adv Exp Med Biol"},{"key":"3263_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/NRM3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C. The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol. 2012;13:767\u201379. https:\/\/doi.org\/10.1038\/NRM3470.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3263_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A007864","author":"K Willert","year":"2012","unstructured":"Willert K, Nusse R. Wnt proteins. Cold Spring Harb Perspect Biol. 2012. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A007864. 4:.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3263_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1245\/ASO.2003.05.003","volume":"10","author":"AM Lowy","year":"2003","unstructured":"Lowy AM, Fenoglio-Preiser C, Kim OJ, et al. Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol. 2003;10:284\u201390. https:\/\/doi.org\/10.1245\/ASO.2003.05.003.","journal-title":"Ann Surg Oncol"},{"key":"3263_CR19","doi-asserted-by":"publisher","first-page":"590912","DOI":"10.3389\/fmolb.2020.590912","volume":"7","author":"J Xie","year":"2020","unstructured":"Xie J, Huang L, Lu Y-G, Zheng D-L. Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma. Front Mol Biosci. 2020;7:590912. https:\/\/doi.org\/10.3389\/fmolb.2020.590912.","journal-title":"Front Mol Biosci"},{"key":"3263_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/CANCERS11070904","volume":"11","author":"S El-Sahli","year":"2019","unstructured":"El-Sahli S, Xie Y, Wang L, Liu S. Wnt signaling in cancer metabolism and immunity. Cancers (Basel). 2019;11:904. https:\/\/doi.org\/10.3390\/CANCERS11070904.","journal-title":"Cancers (Basel)"},{"key":"3263_CR21","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1080\/21691401.2019.1647222","volume":"47","author":"KL Tang","year":"2019","unstructured":"Tang KL, Tang HY, Du Y, et al. MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt\/\u03b2-catenin pathway by targeting phospholipase D1. Artif Cells Nanomed Biotechnol. 2019;47:3278\u201385. https:\/\/doi.org\/10.1080\/21691401.2019.1647222.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3263_CR22","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Jim\u00e9nez C, Garc\u00eda-Mart\u00ednez JM, Chocarro-Calvo A, De la Vieja A. A new link between diabetes and cancer: enhanced WNT\/\u03b2-catenin signaling by high glucose. J Mol Endocrinol. 2013;52. https:\/\/doi.org\/10.1530\/JME-13-0152.","DOI":"10.1530\/JME-13-0152"},{"key":"3263_CR23","doi-asserted-by":"publisher","unstructured":"Wei Z, Wang Y, Jiang L, et al. miR-223 regulates oral squamous cell carcinoma metastasis through the Wnt\/\u03b2-catenin signaling pathway. Oral Oncol. 2020;109. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104941.","DOI":"10.1016\/j.oraloncology.2020.104941"},{"key":"3263_CR24","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.2741\/4875","volume":"25","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Cao Y, Qiu Y, et al. Progression of squamous cell carcinoma is regulated by miR-139-5p\/CXCR4. Front Bioscience - Landmark. 2020;25:1732\u201345. https:\/\/doi.org\/10.2741\/4875.","journal-title":"Front Bioscience - Landmark"},{"key":"3263_CR25","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.18632\/ONCOTARGET.2511","volume":"5","author":"T Wang","year":"2014","unstructured":"Wang T, Guo S, Liu Z, et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014;5:10293\u2013306. https:\/\/doi.org\/10.18632\/ONCOTARGET.2511.","journal-title":"Oncotarget"},{"key":"3263_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","volume":"124","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31\u201382. https:\/\/doi.org\/10.1016\/B978-0-12-411638-2.00002-1.","journal-title":"Adv Cancer Res"},{"key":"3263_CR27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1084\/JEM.20030267","volume":"198","author":"T Schioppa","year":"2003","unstructured":"Schioppa T, Uranchimeg B, Saccani A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 2003;198:1391\u2013402. https:\/\/doi.org\/10.1084\/JEM.20030267.","journal-title":"J Exp Med"},{"key":"3263_CR28","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1080\/15384101.2019.1662257","volume":"18","author":"GH Li","year":"2019","unstructured":"Li GH, Ma ZH, Wang X. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt\/\u03b2-catenin signaling pathway. Cell Cycle. 2019;18:2902\u201313. https:\/\/doi.org\/10.1080\/15384101.2019.1662257.","journal-title":"Cell Cycle"},{"key":"3263_CR29","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.2147\/OTT.S153888","volume":"11","author":"L Liu","year":"2018","unstructured":"Liu L, Jiang H, Zhao J, Wen H. MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt\/\u03b2-catenin signaling pathway. Onco Targets Ther. 2018;11:5111\u20139. https:\/\/doi.org\/10.2147\/OTT.S153888.","journal-title":"Onco Targets Ther"},{"key":"3263_CR30","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1007\/S11033-019-04895-4","volume":"46","author":"M Pashirzad","year":"2019","unstructured":"Pashirzad M, Fiuji H, Khazei M, et al. Role of Wnt3a in the pathogenesis of cancer, current status and prospective. Mol Biol Rep. 2019;46:5609\u201316. https:\/\/doi.org\/10.1007\/S11033-019-04895-4.","journal-title":"Mol Biol Rep"},{"key":"3263_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.archoralbio.2017.07.009","volume":"83","author":"B Liu","year":"2017","unstructured":"Liu B, Chen W, Cao G, et al. MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway. Arch Oral Biol. 2017;83:92\u20136. https:\/\/doi.org\/10.1016\/j.archoralbio.2017.07.009.","journal-title":"Arch Oral Biol"},{"key":"3263_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/S11010-013-1959-1","volume":"390","author":"L Wan","year":"2014","unstructured":"Wan L, Zhang L, Fan K, Wang J. MiR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cells. Mol Cell Biochem. 2014;390:85\u201391. https:\/\/doi.org\/10.1007\/S11010-013-1959-1.","journal-title":"Mol Cell Biochem"},{"key":"3263_CR33","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1158\/0008-5472.CAN-13-2193","volume":"74","author":"Q Song","year":"2014","unstructured":"Song Q, Xu Y, Yang C, et al. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res. 2014;74:3031\u201342. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2193.","journal-title":"Cancer Res"},{"key":"3263_CR34","first-page":"3542","volume":"10","author":"N Zhang","year":"2018","unstructured":"Zhang N, Wei ZL, Yin J, et al. Mir-106a* inhibits oral squamous cell carcinoma progression by directly targeting MeCP2 and suppressing the Wnt\/\u03b2-catenin signaling pathway. Am J Transl Res. 2018;10:3542\u201354.","journal-title":"Am J Transl Res"},{"key":"3263_CR35","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.26355\/eurrev_202005_21169","volume":"24","author":"TL Zheng","year":"2020","unstructured":"Zheng TL, Cen K. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt\/\u03b2-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24:4803\u20139. https:\/\/doi.org\/10.26355\/eurrev_202005_21169.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3263_CR36","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1158\/0008-5472.CAN-14-0978","volume":"74","author":"SG Shiah","year":"2014","unstructured":"Shiah SG, Hsiao JR, Chang WM, et al. Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b. Cancer Res. 2014;74:7560\u201372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0978.","journal-title":"Cancer Res"},{"key":"3263_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/J.BBRC.2003.07.019","volume":"313","author":"C Tokunaga","year":"2004","unstructured":"Tokunaga C, Yoshino KI, Yonezawa K. mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun. 2004;313:443\u20136. https:\/\/doi.org\/10.1016\/J.BBRC.2003.07.019.","journal-title":"Biochem Biophys Res Commun"},{"key":"3263_CR38","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/J.BBAMCR.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK. Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011;1813:1978\u201386. https:\/\/doi.org\/10.1016\/J.BBAMCR.2011.03.010.","journal-title":"Biochim Biophys Acta"},{"key":"3263_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/S11892-009-0034-5","volume":"9","author":"DN Gross","year":"2009","unstructured":"Gross DN, Wan M, Birnbaum MJ. The role of FOXO in the regulation of metabolism. Curr Diab Rep. 2009;9:208\u201314. https:\/\/doi.org\/10.1007\/S11892-009-0034-5.","journal-title":"Curr Diab Rep"},{"key":"3263_CR40","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3892\/etm.2020.8614","volume":"19","author":"H Song","year":"2020","unstructured":"Song H, Lai L, Liu M, et al. Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1. Exp Ther Med. 2020;19:3707\u201315. https:\/\/doi.org\/10.3892\/etm.2020.8614.","journal-title":"Exp Ther Med"},{"key":"3263_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/1947601911423029","volume":"2","author":"MC Archer","year":"2011","unstructured":"Archer MC. Role of Sp transcription factors in the regulation of cancer cell metabolism. Genes Cancer. 2011;2:712\u20139. https:\/\/doi.org\/10.1177\/1947601911423029.","journal-title":"Genes Cancer"},{"key":"3263_CR42","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1111\/jcmm.14189","volume":"23","author":"H Zhang","year":"2019","unstructured":"Zhang H, Jiang S, Guo L, Li X. MicroRNA-1258, regulated by c-Myb, inhibits growth and epithelial-to-mesenchymal transition phenotype via targeting SP1 in oral squamous cell carcinoma. J Cell Mol Med. 2019;23:2813\u201321. https:\/\/doi.org\/10.1111\/jcmm.14189.","journal-title":"J Cell Mol Med"},{"key":"3263_CR43","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/or.2017.6157","volume":"39","author":"M Li","year":"2018","unstructured":"Li M, Li Z, Wang X, et al. Function of miR-152 as tumor suppressor in oral squamous cell carcinoma cells by targeting c-MET. Oncol Rep. 2018;39:1173\u201380. https:\/\/doi.org\/10.3892\/or.2017.6157.","journal-title":"Oncol Rep"},{"key":"3263_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/1440-1681.13235","volume":"47","author":"Z Cui","year":"2020","unstructured":"Cui Z, Bao X, Liu Q, et al. MicroRNA-378-3p\/5p represses proliferation and induces apoptosis of oral squamous carcinoma cells via targeting KLK4. Clin Exp Pharmacol Physiol. 2020;47:713\u201324. https:\/\/doi.org\/10.1111\/1440-1681.13235.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"28","key":"3263_CR45","doi-asserted-by":"publisher","first-page":"E2572","DOI":"10.1073\/pnas.1304318110","volume":"110","author":"Y Jin","year":"2013","unstructured":"Jin Y, Qu S, Tesikova M, et al Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer. Proc Natl Acad Sci U S A. 2013;110(28):E2572\u201381. https:\/\/doi.org\/10.1073\/PNAS.1304318110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3263_CR46","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.26355\/EURREV_202004_20833","volume":"24","author":"C Li","year":"2020","unstructured":"Li C, Lin XF, Wang JN, Ren XS. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K\/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2020;24:3701\u20139. https:\/\/doi.org\/10.26355\/EURREV_202004_20833.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3263_CR47","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.18632\/ONCOTARGET.1812","volume":"5","author":"L Gao","year":"2014","unstructured":"Gao L, Wang X, Wang X, et al. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2\/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma. Oncotarget. 2014;5:2562. https:\/\/doi.org\/10.18632\/ONCOTARGET.1812.","journal-title":"Oncotarget"},{"key":"3263_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biopha.2015.02.011","volume":"71","author":"H Chi","year":"2015","unstructured":"Chi H. MiR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling. Biomed Pharmacotherapy. 2015;71:53\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2015.02.011.","journal-title":"Biomed Pharmacotherapy"},{"key":"3263_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.CMET.2019.05.016","volume":"30","author":"Z Hu","year":"2019","unstructured":"Hu Z, Qu G, Yu X, et al. Acylglycerol kinase maintains metabolic state and immune responses of CD8\u2009+\u2009T cells. Cell Metab. 2019;30:290\u2013e3025. https:\/\/doi.org\/10.1016\/J.CMET.2019.05.016.","journal-title":"Cell Metab"},{"issue":"10","key":"3263_CR50","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41419-019-1971-9","volume":"10","author":"L Gao","year":"2019","unstructured":"Gao L, Dou ZC, Ren WH, et al CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT\/ERK\u00bd\/mTOR signaling pathways in oral squamous cell carcinomas. Cell Death Dis. 2019;10(10):745. https:\/\/doi.org\/10.1038\/s41419-019-1971-9.","journal-title":"Cell Death Dis"},{"key":"3263_CR51","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1158\/0008-5472.CAN-11-0368","volume":"71","author":"A Uesugi","year":"2011","unstructured":"Uesugi A, Kozaki K-I, Tsuruta T, et al. The tumor suppressive MicroRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011;71:5765\u201378. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0368.","journal-title":"Cancer Res"},{"key":"3263_CR52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3892\/mmr.2012.971","volume":"6","author":"B Yan","year":"2012","unstructured":"Yan B, Fu Q, Lai L, et al. Downregulation of MicroRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Mol Med Rep. 2012;6:675\u201381. https:\/\/doi.org\/10.3892\/mmr.2012.971.","journal-title":"Mol Med Rep"},{"key":"3263_CR53","doi-asserted-by":"publisher","unstructured":"Mallela K, Shivananda S, Gopinath KS, Kumar A. Oncogenic role of MiR-130a in oral squamous cell carcinoma. Sci Rep. 2021;11. https:\/\/doi.org\/10.1038\/s41598-021-87388-4.","DOI":"10.1038\/s41598-021-87388-4"},{"key":"3263_CR54","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/jop.12936","volume":"48","author":"CC Ieong","year":"2019","unstructured":"Ieong CC, Ma J, Lai W. RALBP1 regulates oral cancer cells via Akt and is a novel target of miR-148a-3p and miR-148b-3p. J Oral Pathol Med. 2019;48:919\u201328. https:\/\/doi.org\/10.1111\/jop.12936.","journal-title":"J Oral Pathol Med"},{"key":"3263_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80054-4","volume":"1","author":"S Kasibhatla","year":"1998","unstructured":"Kasibhatla S, Brunner T, Genestier L, et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell. 1998;1:543\u201351. https:\/\/doi.org\/10.1016\/S1097-2765(00)80054-4.","journal-title":"Mol Cell"},{"key":"3263_CR56","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","volume":"47","author":"R Sen","year":"1986","unstructured":"Sen R, Baltimore D. Inducibility of kappa Immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47:921\u20138. https:\/\/doi.org\/10.1016\/0092-8674(86)90807-X.","journal-title":"Cell"},{"key":"3263_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/S00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch. 2005;446:475\u201382. https:\/\/doi.org\/10.1007\/S00428-005-1264-9.","journal-title":"Virchows Arch"},{"key":"3263_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/SIGTRANS.2017.23","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017. https:\/\/doi.org\/10.1038\/SIGTRANS.2017.23. 2:.","journal-title":"Signal Transduct Target Ther"},{"key":"3263_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/J.CELL.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008;132:344\u201362. https:\/\/doi.org\/10.1016\/J.CELL.2008.01.020.","journal-title":"Cell"},{"key":"3263_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8:49\u201362. https:\/\/doi.org\/10.1038\/nrm2083.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3263_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/J.1349-7006.2011.02174.X","volume":"103","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Nakayama H, Yoshitake Y, et al. Selective Inhibition of nuclear factor-\u03baB by nuclear factor-\u03baB essential modulator-binding domain peptide suppresses the metastasis of highly metastatic oral squamous cell carcinoma. Cancer Sci. 2012;103:455\u201363. https:\/\/doi.org\/10.1111\/J.1349-7006.2011.02174.X.","journal-title":"Cancer Sci"},{"key":"3263_CR62","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.26355\/eurrev_202004_20835","volume":"24","author":"FY Zhu","year":"2020","unstructured":"Zhu FY, Gan CW, Wang MX, et al. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-\u03baB signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24:3717\u201323. https:\/\/doi.org\/10.26355\/eurrev_202004_20835.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3263_CR63","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.3892\/or.2015.4323","volume":"34","author":"Z Liu","year":"2015","unstructured":"Liu Z, Diep C, Mao T, et al. MicroRNA-92b promotes tumor growth and activation of NF-\u03baB signaling via regulation of NLK in oral squamous cell carcinoma. Oncol Rep. 2015;34:2961\u20138. https:\/\/doi.org\/10.3892\/or.2015.4323.","journal-title":"Oncol Rep"},{"key":"3263_CR64","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3892\/ijmm.2019.4083","volume":"43","author":"D Wei","year":"2019","unstructured":"Wei D, Shen B, Wang W, et al. MicroRNA-199a-5p functions as a tumor suppressor in oral squamous cell carcinoma via targeting the IKK\u03b2\/NF-\u03baB signaling pathway. Int J Mol Med. 2019;43:1585\u201396. https:\/\/doi.org\/10.3892\/ijmm.2019.4083.","journal-title":"Int J Mol Med"},{"key":"3263_CR65","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1159\/000493411","volume":"49","author":"N Li","year":"2018","unstructured":"Li N, Nan CC, Zhong XY, et al. miR-182-5p promotes growth in oral squamous cell carcinoma by inhibiting CAMK2N1. Cell Physiol Biochem. 2018;49:1329\u201341. https:\/\/doi.org\/10.1159\/000493411.","journal-title":"Cell Physiol Biochem"},{"key":"3263_CR66","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/NRG.2016.20","volume":"17","author":"DW Thomson","year":"2016","unstructured":"Thomson DW, Dinger ME. Endogenous MicroRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272\u201383. https:\/\/doi.org\/10.1038\/NRG.2016.20.","journal-title":"Nat Rev Genet"},{"key":"3263_CR67","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3389\/fonc.2019.01054","volume":"9","author":"G Huang","year":"2019","unstructured":"Huang G, zhao, Wu Q, qing, Zheng Z et al. nan, (2019) Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma. Front Oncol 9:1054. https:\/\/doi.org\/10.3389\/FONC.2019.01054","journal-title":"Frontiers in oncology"},{"issue":"12","key":"3263_CR68","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41419-020-03257-4","volume":"11","author":"Z nan Zheng","year":"2020","unstructured":"nan Zheng Z, zhao Huang G, qing Wu Q, et al. NF-\u03baB-mediated LncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR-125b-2-3p\/Slug. Cell Death Dis. 2020;11(12):1055. https:\/\/doi.org\/10.1038\/s41419-020-03257-4","journal-title":"Cell Death Dis"},{"key":"3263_CR69","doi-asserted-by":"publisher","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999) Notch signaling: Cell fate control and signal integration in development. Science (1979) 284:770\u2013776. https:\/\/doi.org\/10.1126\/science.284.5415.770","DOI":"10.1126\/science.284.5415.770"},{"key":"3263_CR70","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/PHYSREV.00005.2017","volume":"97","author":"C Siebel","year":"2017","unstructured":"Siebel C, Lendahl U. Notch signaling in Development, tissue Homeostasis, and disease. Physiol Rev. 2017;97:1235\u201394. https:\/\/doi.org\/10.1152\/PHYSREV.00005.2017.","journal-title":"Physiol Rev"},{"key":"3263_CR71","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3892\/ijmm.2018.3769","volume":"42","author":"J Zhang","year":"2018","unstructured":"Zhang J, Zheng G, Zhou L, et al. Notch signalling induces epithelial-mesenchymal transition to promote metastasis in oral squamous cell carcinoma. Int J Mol Med. 2018;42:1909\u201316. https:\/\/doi.org\/10.3892\/ijmm.2018.3769.","journal-title":"Int J Mol Med"},{"key":"3263_CR72","doi-asserted-by":"publisher","first-page":"642352","DOI":"10.3389\/fcell.2021.642352","volume":"9","author":"A Akil","year":"2021","unstructured":"Akil A, Guti\u00e9rrez-Garc\u00eda AK, Guenter R, et al Notch signaling in vascular endothelial Cells, angiogenesis, and tumor progression: an update and prospective. Front Cell Dev Biol. 2021;9:642352. https:\/\/doi.org\/10.3389\/fcell.2021.642352.","journal-title":"Front Cell Dev Biol"},{"key":"3263_CR73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2334\/josnusd.15-0535","volume":"58","author":"T Osathanon","year":"2016","unstructured":"Osathanon T, Nowwarote N, Pavasant P. Expression and influence of Notch signaling in oral squamous cell carcinoma. J Oral Sci. 2016;58:283\u201394. https:\/\/doi.org\/10.2334\/josnusd.15-0535.","journal-title":"J Oral Sci"},{"key":"3263_CR74","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/01635581.2019.1651878","volume":"72","author":"Y Guo","year":"2020","unstructured":"Guo Y, Chen Y, Liu H, Yan W. Alpinetin inhibits oral squamous cell carcinoma proliferation via miR-211-5p upregulation and Notch pathway deactivation. Nutr Cancer. 2020;72:757\u201367. https:\/\/doi.org\/10.1080\/01635581.2019.1651878.","journal-title":"Nutr Cancer"},{"key":"3263_CR75","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.2147\/DDDT.S92702","volume":"9","author":"L Wu","year":"2015","unstructured":"Wu L, Yang W, Zhang SN, Lu J, Bin. Alpinetin inhibits lung cancer progression and elevates sensitization drug-resistant lung cancer cells to cis-diammined dichloridoplatium. Drug Des Devel Ther. 2015;9:6119\u201327. https:\/\/doi.org\/10.2147\/DDDT.S92702.","journal-title":"Drug Des Devel Ther"},{"key":"3263_CR76","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3892\/mmr.2012.1243","volume":"7","author":"Z Wang","year":"2013","unstructured":"Wang Z, Lu W, Li Y, Tang B. Alpinetin promotes Bax translocation, induces apoptosis through the mitochondrial pathway and arrests human gastric cancer cells at the G2\/M phase. Mol Med Rep. 2013;7:915\u201320. https:\/\/doi.org\/10.3892\/mmr.2012.1243.","journal-title":"Mol Med Rep"},{"key":"3263_CR77","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3892\/ijmm.2012.884","volume":"29","author":"J Du","year":"2012","unstructured":"Du J, Tang B, Wang J, et al. Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Int J Mol Med. 2012;29:607\u201312. https:\/\/doi.org\/10.3892\/ijmm.2012.884.","journal-title":"Int J Mol Med"},{"issue":"1 21","key":"3263_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12935-021-01808-Z","volume":"21","author":"B Jia","year":"2021","unstructured":"Jia B, Dao J, Han J, et al. LINC00958 promotes the proliferation of TSCC via miR-211-5p\/CENPK axis and activating the JAK\/STAT3 signaling pathway. Cancer Cell Int 2021. 2021;21(1 21):1\u201316. https:\/\/doi.org\/10.1186\/S12935-021-01808-Z.","journal-title":"Cancer Cell Int 2021"},{"key":"3263_CR79","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41417-020-00289-y","volume":"29","author":"W Liu","year":"2021","unstructured":"Liu W, Shi X, Wang B. microRNA-133a exerts tumor suppressive role in oral squamous cell carcinoma through the Notch signaling pathway via downregulation of CTBP2. Cancer Gene Ther. 2021;29:62\u201372. https:\/\/doi.org\/10.1038\/s41417-020-00289-y.","journal-title":"Cancer Gene Ther"},{"key":"3263_CR80","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/EDRV.22.2.0428","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers, Gibson, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22:153\u201383. https:\/\/doi.org\/10.1210\/EDRV.22.2.0428.","journal-title":"Endocr Rev"},{"key":"3263_CR81","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1158\/1078-0432.CCR-13-0897","volume":"20","author":"K Yumoto","year":"2014","unstructured":"Yumoto K, Eber MR, Berry JE, et al. Molecular pathways: niches in metastatic dormancy. Clin Cancer Res. 2014;20:3384\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0897.","journal-title":"Clin Cancer Res"},{"key":"3263_CR82","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1002\/jcb.27753","volume":"120","author":"J Zheng","year":"2019","unstructured":"Zheng J, Wang J, Jia Y, et al. microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein. J Cell Biochem. 2019;120:4644\u201353. https:\/\/doi.org\/10.1002\/jcb.27753.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3263_CR83","doi-asserted-by":"publisher","first-page":"862879","DOI":"10.1155\/2012\/862879","volume":"2012","author":"S Tanida","year":"2012","unstructured":"Tanida S, Mizoshita T, Ozeki K, et al Mechanisms of cisplatin-Induced apoptosis and of cisplatin sensitivity: potential of BIN1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment. Int J Surg Oncol. 2012;2012(1):862879. https:\/\/doi.org\/10.1155\/2012\/862879.","journal-title":"Int J Surg Oncol"},{"issue":"6","key":"3263_CR84","doi-asserted-by":"publisher","first-page":"BSR20182214","DOI":"10.1042\/BSR20182214","volume":"39","author":"J Ding","year":"2019","unstructured":"Ding J, Sun D, Xie P Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK\/MAPK signaling pathway by down-regulating HOXA1. Biosci Rep. 2019;39(6):BSR20182214. https:\/\/doi.org\/10.1042\/BSR20182214.","journal-title":"Biosci Rep"},{"issue":"3","key":"3263_CR85","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee S, Rauch J, Kolch W Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21(3):1102. https:\/\/doi.org\/10.3390\/ijms21031102.","journal-title":"Int J Mol Sci"},{"key":"3263_CR86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/dna.2017.4095","volume":"37","author":"M Lu","year":"2018","unstructured":"Lu M, Wang C, Chen W, et al. MiR-654-5p targets GRAP to promote Proliferation, Metastasis, and chemoresistance of oral squamous cell carcinoma through Ras\/MAPK signaling. DNA Cell Biol. 2018;37:381\u20138. https:\/\/doi.org\/10.1089\/dna.2017.4095.","journal-title":"DNA Cell Biol"},{"key":"3263_CR87","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejphar.2019.03.040","volume":"853","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Xing D. Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221. Eur J Pharmacol. 2019;853:353\u201363. https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.040.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3263_CR88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41368-021-00115-7","volume":"13","author":"J Yang","year":"2021","unstructured":"Yang J, Shi X, Yang M, et al Glycolysis reprogramming in cancer-associated fibroblasts promotes the growth of oral cancer through the LncRNA H19\/miR-675-5p\/PFKFB3 signaling pathway. Int J Oral Sci. 2021;13(1):12. https:\/\/doi.org\/10.1038\/s41368-021-00115-7.","journal-title":"Int J Oral Sci"},{"issue":"1","key":"3263_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-4598-13-6","volume":"13","author":"YC Yen","year":"2014","unstructured":"Yen YC, Shiah SG, Chu HC, et al Reciprocal regulation of MicroRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer. 2014;13(1):6. https:\/\/doi.org\/10.1186\/1476-4598-13-6.","journal-title":"Mol Cancer"},{"key":"3263_CR90","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.18632\/ONCOTARGET.23826","volume":"9","author":"B Hou","year":"2018","unstructured":"Hou B, Ishinaga H, Midorikawa K, et al. Let-7c inhibits migration and epithelial\u2013mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2. Oncotarget. 2018;9:8927\u201340. https:\/\/doi.org\/10.18632\/ONCOTARGET.23826.","journal-title":"Oncotarget"},{"issue":"4","key":"3263_CR91","doi-asserted-by":"publisher","first-page":"a022145","DOI":"10.1101\/cshperspect.a022145","volume":"9","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Alexander PB, Wang XF TGF-\u03b2 family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 2017;9(4):a022145. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A022145.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3263_CR92","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21655979.2019.1710925","volume":"11","author":"L Chen","year":"2020","unstructured":"Chen L, Zhu Q, Lu L, Liu Y. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-\u03b21. Bioengineered. 2020;11:91\u2013102. https:\/\/doi.org\/10.1080\/21655979.2019.1710925.","journal-title":"Bioengineered"},{"key":"3263_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/PATH.4752","volume":"240","author":"CM Cheng","year":"2016","unstructured":"Cheng CM, Shiah SG, Huang CC, et al. Up-regulation of miR-455-5p by the TGF-\u03b2-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. J Pathol. 2016;240:38\u201349. https:\/\/doi.org\/10.1002\/PATH.4752.","journal-title":"J Pathol"},{"key":"3263_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3727\/096504019X15761480623959","volume":"28","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jia RZ, Diao S, et al. miRNA-101 targets TGF-\u03b2R1 to retard the progression of oral squamous cell carcinoma. Oncol Res. 2020;28:203\u201312. https:\/\/doi.org\/10.3727\/096504019X15761480623959.","journal-title":"Oncol Res"},{"key":"3263_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/S13287-020-1576-3","author":"X You","year":"2020","unstructured":"You X, Zhou Z, Chen W, et al. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-\u03b2 signaling pathway. Stem Cell Res Ther. 2020. https:\/\/doi.org\/10.1186\/S13287-020-1576-3. 11:.","journal-title":"Stem Cell Res Ther"},{"key":"3263_CR96","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3892\/MMR.2019.10403","volume":"20","author":"C Huang","year":"2019","unstructured":"Huang C, Song H, Lai L. The role and mechanism of microRNA-18a-5p in oral squamous cell carcinoma. Mol Med Rep. 2019;20:1637\u201344. https:\/\/doi.org\/10.3892\/MMR.2019.10403.","journal-title":"Mol Med Rep"},{"key":"3263_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/S10456-013-9394-1","volume":"17","author":"YY Wu","year":"2014","unstructured":"Wu YY, Chen YL, Jao YC, et al. miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by Silencing neuropilin 1. Angiogenesis. 2014;17:247\u201360. https:\/\/doi.org\/10.1007\/S10456-013-9394-1.","journal-title":"Angiogenesis"},{"key":"3263_CR98","doi-asserted-by":"publisher","first-page":"10309","DOI":"10.1158\/0008-5472.CAN-07-3256","volume":"67","author":"A Matsushita","year":"2007","unstructured":"Matsushita A, G\u00f6tze T, Korc M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 2007;67:10309\u201316. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3256.","journal-title":"Cancer Res"},{"key":"3263_CR99","doi-asserted-by":"publisher","first-page":"13824","DOI":"10.1111\/jcmm.15972","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jiang Y, Chen L. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: an in vivo and vitro study based on microarray data. J Cell Mol Med. 2020;24:13824\u201336. https:\/\/doi.org\/10.1111\/jcmm.15972.","journal-title":"J Cell Mol Med"},{"key":"3263_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/mps4010010","volume":"4","author":"I Dasgupta","year":"2021","unstructured":"Dasgupta I, Chatterjee A. Recent advances in MiRNA delivery systems. Methods Protoc. 2021;4:1\u201318. https:\/\/doi.org\/10.3390\/mps4010010.","journal-title":"Methods Protoc"},{"issue":"6","key":"3263_CR101","doi-asserted-by":"publisher","first-page":"e1662","DOI":"10.1002\/wrna.1662","volume":"12","author":"LF Sempere","year":"2021","unstructured":"Sempere LF, Azmi AS, Moore A microRNA-based diagnostic and therapeutic applications in cancer medicine. Wiley Interdiscip Rev RNA. 2021;12(6):e1662. https:\/\/doi.org\/10.1002\/wrna.1662.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3263_CR102","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/J.JCONREL.2013.09.015","volume":"172","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang Z, Gemeinhart RA. Progress in MicroRNA delivery. J Control Release. 2013;172:962\u201374. https:\/\/doi.org\/10.1016\/J.JCONREL.2013.09.015.","journal-title":"J Control Release"},{"key":"3263_CR103","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1039\/C2CS35094G","volume":"41","author":"SK Samal","year":"2012","unstructured":"Samal SK, Dash M, Vlierberghe S, Van, et al. Cationic polymers and their therapeutic potential. Chem Soc Rev. 2012;41:7147\u201394. https:\/\/doi.org\/10.1039\/C2CS35094G.","journal-title":"Chem Soc Rev"},{"key":"3263_CR104","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/IJN.S68861","volume":"10","author":"G Bozzuto","year":"2015","unstructured":"Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975\u201399. https:\/\/doi.org\/10.2147\/IJN.S68861.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3263_CR105","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/S12672-024-01341-1","volume":"15","author":"T Zhou","year":"2024","unstructured":"Zhou T, Qiu JM, Han XJ, et al. The application of nanoparticles in delivering small RNAs for cancer therapy. Discover Oncol 2024. 2024;15(1):500. https:\/\/doi.org\/10.1007\/S12672-024-01341-1.","journal-title":"Discover Oncol 2024"},{"key":"3263_CR106","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.2147\/IJN.S524558","volume":"20","author":"YP Fang","year":"2025","unstructured":"Fang YP, Lin YC, Lin CY, et al. Transmucosal delivery of miR-30c-5p by Chitosan nanoparticles for oral squamous cell carcinoma. Int J Nanomed. 2025;20:9179\u201394. https:\/\/doi.org\/10.2147\/IJN.S524558.","journal-title":"Int J Nanomed"},{"key":"3263_CR107","doi-asserted-by":"publisher","first-page":"1447953","DOI":"10.3389\/fmolb.2024.1447953","volume":"11","author":"P Ubanako","year":"2024","unstructured":"Ubanako P, Mirza S, Ruff P, Penny C Exosome-mediated delivery of SiRNA molecules in cancer therapy: triumphs and challenges. Front Mol Biosci. 2024;11:1447953. https:\/\/doi.org\/10.3389\/FMOLB.2024.1447953\/PDF.","journal-title":"Front Mol Biosci"},{"key":"3263_CR108","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.12659\/MSM.918504","volume":"25","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Li L, Pan S, et al. Targeting Frizzled-7 decreases stemness and chemotherapeutic resistance in gastric cancer cells by suppressing Myc expression. Med Sci Monit. 2019;25:8637\u201344. https:\/\/doi.org\/10.12659\/MSM.918504.","journal-title":"Med Sci Monit"},{"key":"3263_CR109","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/0008-5472.CAN-20-1488","volume":"81","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao G, Condello S, et al. Frizzled-7 identifies Platinum-Tolerant ovarian cancer cells susceptible to ferroptosis. Cancer Res. 2021;81:384\u201399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1488.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03263-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03263-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03263-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:03:59Z","timestamp":1775649839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03263-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3263"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03263-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}